Cartiva’s Synthetic Cartilage Implant used in 1st surgery: 5 things to know

Cartiva’s Synthetic Cartilage Implant has been used to treat the first patient in its GRIP Study.

Advertisement

Here are five things to know:

 

1. The GRIP Study is a multi-center study evaluating the safety and effectiveness of the implant in the treatment of carpometacarpal joint osteoarthritis at the base of the thumb.

 

2. Erin Brown, MD, co-principal investigator of the study, performed the first surgery at UBC Hospital in Vancouver in Canada.

 

3. Cartiva SCI is a proprietary hydrogel polymer device designed to mimic natural cartilage.

 

4. The implant aims to minimize bone resection and preserve the trapezium.

 

5. Cartiva develops and markets solutions for patients with osteoarthritis, cartilage damage and other musculoskeletal conditions.

 

More articles on devices:
SpineGuard sells 1k units in Q3 in the United States: 5 key notes
Hackensack University Medical Center buys spine surgery robot: 4 key notes
Montana board grants Bacterin $100k: 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.